Purdue Pharma L.P. et al v. Commonwealth of Massachusetts et al

  1. September 21, 2023

    Canadian Tribe Denied More Time To Appeal Purdue Injunction

    A New York bankruptcy judge Thursday denied a Canadian First Nation's request to extend its deadline to appeal an injunction blocking it from moving forward with a state court opioid suit against bankrupt drugmaker Purdue Pharma LP.

  2. August 23, 2023

    Canadian Tribe's Lawsuit 'Perplexing,' Purdue Tells NY Court

    Purdue Pharma LP has asked a New York bankruptcy judge to reject a Canadian First Nation's attempt to move opioid claims forward against the drugmaker and its Sackler family owners, saying the tribe failed to meet a notice of appeal deadline to challenge the newest of many injunctions.

  3. January 24, 2023

    Purdue Warns Tribe's NY Lawsuit Could 'Blow Up' Ch. 11 Plan

    Purdue Pharma LP urged a New York bankruptcy court on Tuesday to reject a demand from an Indigenous tribe in Canada to lift a freeze on litigation against the bankrupt drugmaker and its Sackler family owners so the tribe can pursue its claims against the Sacklers in state court.

  4. December 21, 2021

    Purdue Asks To Keep Lawsuits Frozen Pending Ch. 11 Appeal

    Purdue Pharma LP has asked a bankruptcy court to maintain a two-year freeze on more than 2,600 opioid-related lawsuits to give the company time to regroup after a New York federal court found its Chapter 11 reorganization plan invalid.

  5. May 07, 2021

    Purdue Asks For Another Month's Hold On Opioid Suits

    Purdue Pharma is asking a New York bankruptcy judge for another 27-day extension of an injunction freezing opioid suits against the company and its owners, saying it needs more time to ensure it gets court approval for its Chapter 11 plan disclosures.

  6. April 08, 2021

    Purdue Wants Another Month's Reprieve From Opioid Suits

    Purdue Pharma has asked a New York bankruptcy judge for another month of relief from lawsuits over its opioid sales, saying negotiations on the final form of its Chapter 11 plan are at a "critical stage."

  7. March 24, 2021

    Purdue, Sackler Opioid Suits Paused For Another Month

    A New York bankruptcy judge on Wednesday granted Purdue Pharma and its former owners another month's relief from suits over Purdue's opioid sales, saying the continued pause will protect efforts to work out the details of the company's Chapter 11 plan.

  8. March 23, 2021

    Sacklers Say No Ch. 11 Deal Without Injunction Extension

    Members of the Sackler family told a New York bankruptcy court on Tuesday that they would pull back a proposed $4.275 billion cash contribution to a settlement fund if the litigation injunction granted in the Chapter 11 case of OxyContin maker Purdue Pharma isn't extended.

  9. March 22, 2021

    States Say Time Has Come To Let Sackler Suits Proceed

    A group of states asked a New York bankruptcy judge Friday to deny Purdue Pharma's latest request to extend the injunction pausing their suits against the Sackler family, saying allowing their claims to go forward will create a better Chapter 11 plan.

  10. September 30, 2020

    Purdue Pharma Gets OK For Payments, Opioid Suit Shield

    A New York bankruptcy judge on Wednesday gave Purdue Pharma another five months free from opioid suits and permission to make $26 million in employee retention payments after being told claim distribution mediation between the drugmaker and its creditors is bearing fruit.